ePoster Schedule - Research

RESEARCH EPOSTER SCHEDULE
PRESENTATION DATE	CATEGORY	MONITOR	PRESENTATION TIME	PRESENTATION ID	ABSTRACT_TITLE
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	3:00 pm PT	P001	Skin test for immediate hypersensitivity reaction to iodinated contrast media: an individual patient data meta-analysis
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	3:15 pm PT	P002	13.2 mg Intranasal Epinephrine Treatment In Congestion Shows Increased Bioavailability Without Pharmacokinetic And Pharmacodynamic Correlation
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	3:30 pm PT	P003	Safety of Anti-SARS-CoV-2 Monoclonal Antibody Therapies: Clinical Characteristics and Outcomes of Adverse Drug Reactions
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	3:45 pm PT	P004	Impact of Angioedema on the Pharmacokinetics of Epinephrine Following Administration via Sublingual Film
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	4:00 pm PT	P005	Epinephrine Administered via Sublingual Film, Manual Injection, or Auto-Injectors in Healthy Adults: Pharmacodynamic Results
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	4:15 pm PT	P006	NSAID Allergy Labeling and Postpartum Opioid Utilization Following Vaginal or Cesarean Delivery
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	4:30 pm PT	P007	Acute Allergic Rhinitis Increases Endogenous Epinephrine Resulting in Increased Heart Rate
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	4:45 pm PT	P008	Risk Factors for Failing Penicillin Challenge Among Pediatric Patients at a Single Institution
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	5:00 pm PT	P009	Factors Associated with Inequity in Penicillin Allergy Evaluation in a Single-Payer System
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	5:15 pm PT	P010 - COMMUNITY GRANT	Patient Perspectives on Penicillin Allergy Evaluation During Pregnancy: A Qualitative Study
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	5:30 pm PT	P011	Incidence and Predictors of Cutaneous Reactions to the COVID-19 Booster Vaccine
Friday, Nov 10	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	5:45 pm PT	P012	A Single-Period, Single-Dose Study of the Pharmacokinetics of Epinephrine After Administration ARS-1 to Pediatric Subjects
Friday, Nov 10	Aerobiology, Allergens, Allergen Extracts	Monitor 21	3:00 pm PT	P030	Comparative Analysis of Aerobiological Rotating Impaction Devices: Rotorod vs Rotoslide
Friday, Nov 10	Aerobiology, Allergens, Allergen Extracts	Monitor 21	3:15 pm PT	P031	Allergic Sensitization to Inhalant Allergens in the United States
Friday, Nov 10	Aerobiology, Allergens, Allergen Extracts	Monitor 21	3:30 pm PT	P032	A Two Stage Artificial Intelligence (AI) Detection And Classification Model For Pollen Grain (PG) Counting.
Friday, Nov 10	Allergy Diagnostics and Immunotherapy	Monitor 21	3:45 pm PT	P040	Briquilimab, an anti-CD117 antibody, prevents passive systemic anaphylaxis in mice expressing chimeric human/mouse CD117
Friday, Nov 10	Allergy Diagnostics and Immunotherapy	Monitor 21	4:00 pm PT	P041	Allergen sensitization patterns in patients at a Federally Qualified Health Center
Friday, Nov 10	Allergy Diagnostics and Immunotherapy	Monitor 21	4:15 pm PT	P042	Optimizing Utilization of Venom Immunotherapy in an Era of Venom Extract Shortages
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	3:00 pm PT	P050	HAE Prophylaxis by Targeting Prekallikrein With siRNA- Phase 1 Interim Safety Outcomes and Prekallikrein Levels
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	3:15 pm PT	P051	Garadacimab protects against hereditary angioedema attacks from Week 1 in pivotal Phase 3 VANGUARD study
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	3:30 pm PT	P052	Healthcare Experiences Prior to Hereditary Angioedema Diagnosis in Underrepresented Racial/Ethnic Groups in the United States
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	3:45 pm PT	P053	Two-Year Analysis of the Donidalorsen Phase 2 Open-Label Extension Study in Patients With Hereditary Angioedema
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	4:00 pm PT	P054	Two-Year Analysis of Donidalorsen Taken Every 8 Weeks (Q8W) in Patients With Hereditary Angioedema
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	4:15 pm PT	P055	Flow-Cytometry Based Immunoassay Is A Highly Sensitive Method To Quantitate Functional C1-Inhibitor In HAE Patients
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	4:30 pm PT	P056	Real-World Outcomes In Patients With HAE Receiving Lanadelumab Long-Term Prophylaxis For 3 Years Or Longer
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	4:45 pm PT	P057	Burden of Illness in Adult Patients With Hereditary Angioedema: Results From a Multinational Survey
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	5:00 pm PT	P058	Bradykinin Measurement By Mass-Spectrometry Correlates With Angioedema Attack Frequency In Bradykinin-Mediated Angioedema
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	5:15 pm PT	P059	Treatment of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) – A Real-World ACARE Survey
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	5:30 pm PT	P060	Analysis Of Safety Data Of Remibrutinib From Completed Phase 2 Studies In Inflammatory Immune-Mediated Diseases
Friday, Nov 10	Angioedema/Urticaria	Monitor 12	5:45 pm PT	P061	Diagnostic Pathway Differences Across Physician Specialties for Patients with Chronic Spontaneous Urticaria: Real-World Survey
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	3:00 pm PT	P072	Remibrutinib Provides Fast and Clinically Important Improvement of Chronic Spontaneous Urticaria Disease Activity
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	3:15 pm PT	P073	Impact of Baseline Angioedema and IgE on Response to Omalizumab in Chronic Spontaneous Urticaria
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	3:30 pm PT	P074	Remibrutinib Treatment Has No Impact on Blood Counts in Patients with Chronic Spontaneous Urticaria
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	3:45 pm PT	P075	Dupilumab improves itch and urticaria activity across several CSU patient subpopulations: LIBERTY-CSU CUPID Study A
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	4:00 pm PT	P076	Time to Sleep Improvement in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	4:15 pm PT	P077	Burden on Caregivers to Pediatric Patients With Hereditary Angioedema: Results From a Multinational Survey
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	4:30 pm PT	P078	Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment With Them
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	4:45 pm PT	P079	Systemic Manifestations During Symptomatic Episodes In Chronic Spontaneous Urticaria: Results From The Urticaria Voices Study
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	5:00 pm PT	P080	Remibrutinib Achieves Clinically Significant Response in Chronic Spontaneous Urticaria Patients Regardless of Prior Oral Treatments
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	5:15 pm PT	P081	Deucrictibant immediate-release capsule reduces time to end of progression of hereditary angioedema attacks’ manifestations
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	5:30 pm PT	P082	Berotralstat Reduced Attack Rates In Patients With Suspected Bradykinin-Mediated Angioedema: Real-World Outcomes
Friday, Nov 10	Angioedema/Urticaria	Monitor 13	5:45 pm PT	P083	Association of COVID Vaccine Manufacturer to Vaccine Related Urticaria
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	3:00 pm PT	P100	Wildfire-associated Increase In Reliever Use Among US Asthma Patients: Data From A Digital Health Platform
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	3:15 pm PT	P101	Tezepelumab Reduces All Key Inflammatory Biomarker Levels In Patients With Severe Allergic And Eosinophilic Asthma
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	3:30 pm PT	P102	Tezepelumab Reduced OCS Use In OCS-dependent Patients With Severe Asthma: Phase 3b WAYFINDER Interim Results
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	3:45 pm PT	P103	Benralizumab is Effective in Reducing COPD Exacerbations in Patients with Asthma and Concomitant COPD
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	4:00 pm PT	P104	Timing Of Exacerbations With Tezepelumab Versus Placebo In Patients With And Without Symptomatic Perennial Allergy
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	4:15 pm PT	P105	Recent Real-World Biologic Utilization Among Adults With Severe Asthma: Data From The CHRONICLE Study
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	4:30 pm PT	P106	Age, Sex, Obesity, and Controller Therapy Moderate the Relationship between Pediatric Asthma Exacerbations and COVID-19
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	4:45 pm PT	P107	Tezepelumab Efficacy In Patients With Severe Asthma By Blood Eosinophil Count And Perennial Allergy (DESTINATION)
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	5:00 pm PT	P108	Statewide Burden of Asthma across the United States Between 1990-2019: Systematic and Comparative Benchmarking Study
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	5:15 pm PT	P109	Unmet Educational Needs in Asthma Management Guidelines: How to Bridge the Gap?
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	5:30 pm PT	P110	Primary Care Physician Referral Patterns and Awareness of Biologic Therapy for Uncontrolled Asthma
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 14	5:45 pm PT	P111	The Effect of COVID-19 on Pediatric Asthma ICU Admissions at a Single Center.
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	3:00 pm PT	P122	Heterogeneous characteristics of severe asthma patients initiating benralizumab in a real-world setting: the ZEPHYR-4 study
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	3:15 pm PT	P123	Effect of the SARS-CoV-2 pandemic on pediatric asthma health-care utilization in an urban tertiary-care hospital
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	3:30 pm PT	P124	Review Of Biologic Efficacy In Patients With Uncontrolled Asthma By Age At Asthma Onset
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	3:45 pm PT	P125	Can Continuing Education Prepare Health Care Providers to Provide Equitable Asthma Care?
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	4:00 pm PT	P126	Impact of Baseline Characteristics on Long-term Response Following Omalizumab Treatment in Patients with Allergic Asthma
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	4:15 pm PT	P127	Performance of the Asthma Impairment and Risk Questionnaire (AIRQ) compared to existing symptom control measures
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	4:30 pm PT	P128	Adherence To Inhaled Medications In Adults With Asthma Evaluated In The ITA, Inhaler Adherence Test
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	4:45 pm PT	P129	Short-acting Beta2-agonist and Systemic/Inhaled Corticosteroid Exposures in US Adolescents and Adults with Asthma
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	5:00 pm PT	P130	Lower Incidence Of Hypereosinophilia With Tezepelumab Treatment Versus Placebo In The PATHWAY And NAVIGATOR Studies
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	5:15 pm PT	P131	Prevalence of Asthma Attacks and Emergency Department Visits Among US Working Adults, 2020–2021
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	5:30 pm PT	P132	Optimizing School Stock Inhaler Programs for Health Equity: Using EPIS Framework and Logic Models
Friday, Nov 10	Asthma, Other Lower Airway Disorders	Monitor 15	5:45 pm PT	P133	Digihaler System Use By Healthcare Professionals And App Connectivity In Asthma Patients: A Pragmatic Study
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	3:00 pm PT	P150	Transcription Factors Impact Differentiation of T-helper Cells in Development of Endometriosis with Infertility
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	3:15 pm PT	P151	Frequency of T-330G IL-2 Gene SNP in SARS-COVID-19 Patients
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	3:30 pm PT	P152	Diagnostic Utility of Streptococcus Pneumonia Titers in a Single Pediatric, Tertiary Hospital and Clinic System
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	3:45 pm PT	P153	Pioglitazone Restored Mouse Lung mRNA Expression of Core Clock, Inflammation and Metabolism-Related Genes
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	4:00 pm PT	P154	Short-term Observation of Safety and Efficacy of Tolerogenic Dendritic Cells Use in Type-1 Diabetes Mellitus
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	4:15 pm PT	P155	Membrane-bound IgE expression on plasmacytoid dendritic cells (pDCs) and B-cells across total serum IgE levels
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	4:30 pm PT	P156	Reduced Bactericidal Permeability-increasing Protein is Found in Post-COVID-19 Syndrome Patients
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	4:45 pm PT	P157	Young Children With Recurrent Respiratory Infections Have Inadequate Pneumococcal Antibodies
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	5:00 pm PT	P158	Structural Characterization of Linear Aliphatic Amine-linked Triaryl Inhibitors of PD-1/PD-L1 With PD-L1 Dimer
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	5:15 pm PT	P159	Characteristics of Disseminated Coccidioidomycosis in Pediatric Patients
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	5:30 pm PT	P160	Autoimmune Disease with Skin Involvement in Patients with Common Variable Immune Deficiency in Western Ukraine
Friday, Nov 10	Clinical Immunology, Immunodeficiency	Monitor 16	5:45 pm PT	P161	Investigating the Association between Mast Cell Activation Syndrome and Irritable Bowel Syndrome
Friday, Nov 10	Food Allergy	Monitor 17	3:00 pm PT	P180	Efficacy and Safety of ADP101 Multifood Oral Immunotherapy in Food-Allergic Patients in the Harmony Trial
Friday, Nov 10	Food Allergy	Monitor 17	3:15 pm PT	P181	Economic burden of food allergy is greater in households with children allergic to more foods
Friday, Nov 10	Food Allergy	Monitor 17	3:30 pm PT	P182	Characterizing Daily Wear Time and Association with Efficacy of VP250 in the EPITOPE Study
Friday, Nov 10	Food Allergy	Monitor 17	3:45 pm PT	P183-COMMUNITY GRANT	National Needs Assessment for an Infant and Toddler Food Allergy Curriculum for Pediatric Residents
Friday, Nov 10	Food Allergy	Monitor 17	4:00 pm PT	P184	Dupilumab Improves Outcomes in Eosinophilic Esophagitis, Regardless of History of Food Allergy or Dietary Elimination
Friday, Nov 10	Food Allergy	Monitor 17	4:15 pm PT	P185	Investigating GI-Variant Alpha-Gal Syndrome in Pediatric Patients Diagnosed with Functional Abdominal Pain
Friday, Nov 10	Food Allergy	Monitor 17	4:30 pm PT	P186	A Shot To Live: Anaphylaxis Curriculum Enhances Efficacy of Epinephrine Administration for Unassigned Administrators
Friday, Nov 10	Food Allergy	Monitor 17	4:45 pm PT	P187	Understanding Perceived Determinants of Food Allergy in a US Population-Based Sample of Children and Adults
Friday, Nov 10	Food Allergy	Monitor 17	5:00 pm PT	P188	Characteristics of an Adult Cohort with Shellfish Allergy: Comparison by Race
Friday, Nov 10	Food Allergy	Monitor 17	5:15 pm PT	P189	Development of Tolerance In Children with Food Allergy
Friday, Nov 10	Food Allergy	Monitor 17	5:30 pm PT	P190	Food allergy-related healthcare utilization and psychosocial burden is greater among children with more food allergies
Friday, Nov 10	Food Allergy	Monitor 17	5:45 pm PT	P191	Predictors of the Psychosocial Burden in Parents of Food Allergic Children
Friday, Nov 10	Food Allergy	Monitor 18	3:00 pm PT	P202	Prevalence and Incidence of Food Allergies in the US General Population
Friday, Nov 10	Food Allergy	Monitor 18	3:15 pm PT	P203	Anaphylaxis Preparedness In Elementary Schools: Knowledge Gaps Remain Despite Frequent Training
Friday, Nov 10	Food Allergy	Monitor 18	3:30 pm PT	P204	Significance of Serum Specific IgE Food Panel Interpretation in Identifying Potential Food Allergies in Children.
Friday, Nov 10	Food Allergy	Monitor 18	3:45 pm PT	P205	Factors Related to Food Allergy in Asian American Children
Friday, Nov 10	Food Allergy	Monitor 18	4:00 pm PT	P206	Racial Disparities in Allergic Disease in an Urban Pediatric Population
Friday, Nov 10	Food Allergy	Monitor 18	4:15 pm PT	P207	Exploring the Interplay of Epinephrine and Needle Phobia: Implications and Strategies
Friday, Nov 10	Food Allergy	Monitor 18	4:30 pm PT	P208	Eosinophilic esophagitis in children: A multicenter study in Mexico evaluating current practices
Friday, Nov 10	Food Allergy	Monitor 18	4:45 pm PT	P209	Managing Food Allergy: Findings from a Nationwide US Survey of Practicing Allergists
Friday, Nov 10	Food Allergy	Monitor 18	5:00 pm PT	P210	Dupilumab Is Efficacious In Patients With Eosinophilic Esophagitis Regardless Of Prior History Of Comorbidities
Friday, Nov 10	Other Allergies and interaction with other disease	Monitor 19	3:00 pm PT	P225	High Prevalence Of Allergy In Patients With Recurrent Pregnancy Loss
Friday, Nov 10	Other Allergy Immunology Education	Monitor 19	3:15 pm PT	P226	Allergy Immunology Fellowship Education During COVID-19 Pandemic
Friday, Nov 10	Other Atopy and COVID-19	Monitor 19	3:30 pm PT	P227	Assessing Severity Of COVID-19 And The Development Of MIS-C In Pediatric Patients With Atopic Disease
Friday, Nov 10	Other Biologic Therapy	Monitor 19	3:45 pm PT	P228	MMR and Varicella Immunization During Dupilumab Therapy
Friday, Nov 10	Other Biologics, Omalizumab, Biosimilars	Monitor 19	4:00 pm PT	P229	Efficacy and safety of Omalizumab Biosimilar in IgE mediated diseases and multimorbidities
Friday, Nov 10	Other Cannabis education for allergists	Monitor 19	4:15 pm PT	P230-COMMUNITY GRANT	Easing the conversation: Cannabis Education for Allergists
Friday, Nov 10	Other Controlled Allergen Environment	Monitor 19	4:30 pm PT	P231	Meta-Analysis Of In-Study Pollen Data In Environmental Exposure Chambers (EEC) From 2019-2022 Demonstrate High Reproducibility
Friday, Nov 10	Other COPD	Monitor 19	4:45 pm PT	P232	Clinical Outcomes Among Individuals With Alpha-1 Antitrypsin Deficiency Enrolled in Medicare Advantage
Friday, Nov 10	Other Drug Allergy	Monitor 19	5:00 pm PT	P233	Allergy to Sulfonamide Increases Risk of Pneumocystis Jiroveci Pneumonia (PJP) in Bone Marrow Transplant Patients
Friday, Nov 10	Other EoE	Monitor 19	5:15 pm PT	P234	Efficacy of dupilumab on facilitated food introduction in Eosinophilic Esophagitis
Friday, Nov 10	Other Eosinophilic Esophagitis	Monitor 19	5:30 pm PT	P235	Case series on the improvement of pediatric Eosinophilic Esophagitis when using Dupilumab for other indications.
Friday, Nov 10	Other Eosinophilic Gastrointestinal Disease	Monitor 19	5:45 pm PT	P236	Characterizing Pediatric Native American Patients with Eosinophilic Gastrointestinal Disease at a Single Tertiary Care Center
Friday, Nov 10	Quality Improvement	Monitor 21	4:30 pm PT	P250	Gender Disparities In Awards Granted by US Allergy/Immunology Societies
Friday, Nov 10	Quality Improvement	Monitor 21	4:45 pm PT	P251	Assessing outcomes of a Dedicated Referral Pathway for Evaluation of Penicillin Allergy During Pregnancy
Friday, Nov 10	Quality Improvement	Monitor 21	5:00 pm PT	P252	Impact of Multi-language Anaphylaxis Plans in an Outpatient Pediatric Allergy Clinic
Friday, Nov 10	Quality Improvement	Monitor 21	5:15 pm PT	P253	Food Insecurity Screening In Food Allergic Patients
Friday, Nov 10	Quality Improvement	Monitor 21	5:30 pm PT	P254	Self-Directed Learning in the Allergy Immunology Clinic: A Quality Improvement Project
Friday, Nov 10	Quality Improvement	Monitor 21	5:45 pm PT	P255	Assessment Of Knowledge Of Identifying Anaphylaxis And EpiPen Usage Among Residents In A Teaching Hospital
Friday, Nov 10	Rhinitis, Other Upper Airway Disorders	Monitor 18	5:15 pm PT	P270	Baseline Corticosteroid Use and Surgery History Among Patients with CRSwNP in Global AROMA registry
Friday, Nov 10	Rhinitis, Other Upper Airway Disorders	Monitor 18	5:30 pm PT	P271	Baseline Disease Burden Among Patients with Chronic Rhinosinusitis with Nasal Polyps in Global AROMA Registry
Friday, Nov 10	Rhinitis, Other Upper Airway Disorders	Monitor 18	5:45 pm PT	P272	Dupilumab Improves Olfaction In Patients With Chronic Rhinosinusitis With Nasal Polyps Irrespective Of Gender
Friday, Nov 10	Skin Disorders	Monitor 20	3:00 pm PT	P280	Maintenance Of Lebrikizumab Efficacy In Moderate-To-Severe Atopic Dermatitis Patients With Stable Asthma Control
Friday, Nov 10	Skin Disorders	Monitor 20	3:15 pm PT	P281	Effect of Delaying First Newborn Bath on the Prevalence of Atopic Dermatitis in Early Childhood
Friday, Nov 10	Skin Disorders	Monitor 20	3:30 pm PT	P282	Tapinarof Cream Improved Itch In Two Phase 3 Trials Of Moderate To Severe Atopic Dermatitis
Friday, Nov 10	Skin Disorders	Monitor 20	3:45 pm PT	P283	Efficacy of Dupilumab in a 5-Year Open-Label Extension Study of Adults With Moderate-to-Severe Atopic Dermatitis
Friday, Nov 10	Skin Disorders	Monitor 20	4:00 pm PT	P284	Once-Daily Roflumilast Cream 0.15% for Atopic Dermatitis: Pooled Results from INTEGUMENT-1/2 Phase 3 Trials
Friday, Nov 10	Skin Disorders	Monitor 20	4:15 pm PT	P285	Assessing Total Corticosteroid Burden in Atopic Dermatitis and Related Atopic Comorbidities
Friday, Nov 10	Skin Disorders	Monitor 20	4:30 pm PT	P286	Safety and Pharmacokinetics of IMG-007, an OX40 monoclonal antibody, in Healthy Adults
Friday, Nov 10	Skin Disorders	Monitor 20	4:45 pm PT	P287	Safety of Dupilumab in a 5-Year Open-Label Extension Study of Adults With Moderate-to-Severe Atopic Dermatitis
Friday, Nov 10	Skin Disorders	Monitor 20	5:00 pm PT	P288-COMMUNITY GRANT	Asthma and Atopic Dermatitis-related Outcomes in Urban Children
Saturday, Nov 11	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	11:35 am PT	P013	Predictive Factors Of Successful Transition To Outpatient For Patients Undergoing Inpatient Desensitization To Chemotherapeutics
Saturday, Nov 11	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	11:50 am PT	P014	Observing patients with anaphylaxis in the Emergency Room: Should we have guidelines?
Saturday, Nov 11	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	12:05 pm PT	P015	The Noise About SARS-COV-2 Vaccination: A Retrospective Cohort Study Evaluating Tinnitus and Vaccination
Saturday, Nov 11	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	12:20 pm PT	P016	A Review of Pediatric Drug-Induced Anaphylaxis Reports in the FDA Adverse Event Reporting System (FAERS)
Saturday, Nov 11	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	12:35 pm PT	P017	Descriptive Analysis of Elevated Serum Tryptase in a Pediatric Cohort
Saturday, Nov 11	Aerobiology, Allergens, Allergen Extracts	Monitor 21	11:35 am PT	P033	Development of Alternaria-sensitization depends on concurrent Malassezia sensitization demonstrating an interplay of sensitizing fungal allergens
Saturday, Nov 11	Aerobiology, Allergens, Allergen Extracts	Monitor 21	11:50 am PT	P034	Longitudinal Prescribing Patterns of Uncommon Mammalian Allergen Immunotherapy across the U.S. Military Healthcare System
Saturday, Nov 11	Aerobiology, Allergens, Allergen Extracts	Monitor 21	12:05 pm PT	P035	Assessing Vertical Airborne Pollen Disparity Using the Novel PollenEyes, a 3D-Printed Rotating Arm Impactor
Saturday, Nov 11	Allergy Diagnostics and Immunotherapy	Monitor 15	12:20 pm PT	P043	Characterizing clinically "relevant" and "irrelevant" adverse reactions to subcutaneous polymerized house dust mite extracts immunotherapy
Saturday, Nov 11	Allergy Diagnostics and Immunotherapy	Monitor 15	12:35 pm PT	P044	Reduced intra-subject variability of Skin Prick Automated Test to detect sensitization to inhalant allergens
Saturday, Nov 11	Angioedema/Urticaria	Monitor 12	11:35 am PT	P062	Remibrutinib Did Not Impact on Total Serum Immunoglobulin Levels of Patients with Chronic Spontaneous Urticaria
Saturday, Nov 11	Angioedema/Urticaria	Monitor 12	11:50 am PT	P063	Highly Sensitive Digital PCR Assay to Detect KIT D816V Mutation in Suspected Mastocytosis Patients
Saturday, Nov 11	Angioedema/Urticaria	Monitor 12	12:05 pm PT	P064	Berotralstat Reduced Attack Rates Compared To Baseline In Patients With Hereditary Angioedema In Apex-S
Saturday, Nov 11	Angioedema/Urticaria	Monitor 12	12:20 pm PT	P065	CRISPR/Cas9 editing of KLKB1 in Hereditary Angioedema Patients: Updated Results from a Phase 1 Study
Saturday, Nov 11	Angioedema/Urticaria	Monitor 12	12:35 pm PT	P066	Support for STAR-0215 Administered Every Three- or Six-Months for Hereditary Angioedema: Phase 1a Results
Saturday, Nov 11	Angioedema/Urticaria	Monitor 13	11:35 am PT	P084	Long-term quality-of-life and patient-reported improvements with garadacimab for hereditary angioedema: Phase 3 open-label extension study
Saturday, Nov 11	Angioedema/Urticaria	Monitor 13	11:50 am PT	P085	Treatment Patterns Among Individuals with Hereditary Angioedema in the United States
Saturday, Nov 11	Angioedema/Urticaria	Monitor 13	12:05 pm PT	P086	Real-World Quality of Life in Patients with HAE Receiving Lanadelumab or Other Long-Term Prophylaxis
Saturday, Nov 11	Angioedema/Urticaria	Monitor 13	12:20 pm PT	P087	Reasons Not To Treat HAE Attacks And Satisfaction For On-Demand Treatment
Saturday, Nov 11	Angioedema/Urticaria	Monitor 13	12:35 pm PT	P088	Remibrutinib Showed Good Stability of Response in Patients With Chronic Spontaneous Urticaria: Phase 2b Study
Saturday, Nov 11	Asthma, Other Lower Airway Disorders	Monitor 14	11:35 am PT	P112	Efficacy and Safety of Dupilumab in Preschool Children With Atopic Dermatitis and Type 2 Comorbidities
Saturday, Nov 11	Asthma, Other Lower Airway Disorders	Monitor 14	11:50 am PT	P113	Association between neighborhood deprivation index and asthma exacerbation and utilization among individuals with intermittent asthma
Saturday, Nov 11	Asthma, Other Lower Airway Disorders	Monitor 14	12:05 pm PT	P114	Biologic Outcomes Among Adults with Severe Asthma by Age of Onset: Results from CHRONICLE
Saturday, Nov 11	Asthma, Other Lower Airway Disorders	Monitor 14	12:20 pm PT	P115	Safety of As-needed Albuterol-budesonide by Background Inhaled Corticosteroid Maintenance Dose in Adults with Moderate-to-severe Asthma
Saturday, Nov 11	Asthma, Other Lower Airway Disorders	Monitor 14	12:35 pm PT	P116	Perceptions On Use Of A Shared Decision-Making Guide Among Minoritized Patients With Asthma
Saturday, Nov 11	Asthma, Other Lower Airway Disorders	Monitor 15	11:35 am PT	P134	Coexisting Chronic Rhinosinusitis with Nasal Polyps in Patients With Moderate-to-Severe Asthma: The RAPID registry study
Saturday, Nov 11	Asthma, Other Lower Airway Disorders	Monitor 15	11:50 am PT	P135	Risk Factors of Asthma Exacerbations in Patients with Intermittent Asthma
Saturday, Nov 11	Asthma, Other Lower Airway Disorders	Monitor 15	12:05 pm PT	P136	Blood Eosinophil Level Changes With Biologic Initiation: Real-world Data From The CHRONICLE Study
Saturday, Nov 11	Clinical Immunology, Immunodeficiency	Monitor 16	11:35 am PT	P162	CD14 (C-159)T Gene Polymorphism in SARS-CoV-2 Patients in Crimea
Saturday, Nov 11	Clinical Immunology, Immunodeficiency	Monitor 16	11:50 am PT	P163	Oxalic Acid Levels Impact Cytokine Production Leading to Greater Chronic Inflammation in Chronic Kidney Diseases
Saturday, Nov 11	Clinical Immunology, Immunodeficiency	Monitor 16	12:20 pm PT	P165	Mortality in Patients With Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS), a Systematic Literature Review (SLR)
Saturday, Nov 11	Clinical Immunology, Immunodeficiency	Monitor 16	12:35 pm PT	P166	Overall Survival (OS) Among Patients With Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS)
Saturday, Nov 11	Clinical Immunology, Immunodeficiency	Monitor 16	12:05 pm PT	P169-INTL SCHOLARSHIP AWARDEE	Specific Antibody Defect in Bronchiectasis of Unknown Aetiology
Saturday, Nov 11	Food Allergy	Monitor 17	11:35 am PT	P192	Parent Perspectives on Peanut Allergy Oral Immunotherapy Timing for Young Children
Saturday, Nov 11	Food Allergy	Monitor 17	11:50 am PT	P193	Addressing the Research Participation Gap in Food Allergy
Saturday, Nov 11	Food Allergy	Monitor 17	12:05 pm PT	P194	Why Do Those Who Need an Epinephrine Autoinjector Not Carry It?: A Customer Discovery Approach
Saturday, Nov 11	Food Allergy	Monitor 17	12:20 pm PT	P195-COMMUNITY GRANT	Adolescents demonstrate improved comfort with self-management of food allergies with implementation of tailored education visit
Saturday, Nov 11	Food Allergy	Monitor 17	12:35 pm PT	P196	Allergist Access as a Potential Driver of Socioeconomic Disparities in Food Allergy
Saturday, Nov 11	Other Eosinophilic granulomatosis with polyangiitis	Monitor 19	11:35 am PT	P237	Effects of Mepolizumab on Patients With Eosinophilic Granulomatosis With Polyangiitis in the United States
Saturday, Nov 11	Other Eye allergy	Monitor 19	11:50 am PT	P238	Allergic profile in pediatric keratoconus on a third level hospital in northeastern Mexico
Saturday, Nov 11	Other Fellowship Consultation and Training	Monitor 19	12:05 pm PT	P239	TREC Screening Results Have Emerged as a Key Reason for Inpatient Pediatric Allergy/Immunology Consultation
Saturday, Nov 11	Other Health disparity	Monitor 19	12:20 pm PT	P240	Language Barriers are Associated with the Underdiagnosis of Allergy and Immunology Conditions in Children
Saturday, Nov 11	Other Mastocytosis	Monitor 19	12:35 pm PT	P241	Avapritinib Improved Gastrointestinal Symptoms in Patients With Indolent Systemic Mastocytosis: Registrational Double-Blind, Placebo-Controlled PIONEER Study
Saturday, Nov 11	Quality Improvement	Monitor 20	12:20 pm PT	P258	Hybrid Telemedicine For Patient Care: Insights From A Patient Satisfaction Survey
Saturday, Nov 11	Quality Improvement	Monitor 20	12:35 pm PT	P259	A Quality Improvement Initiative Increasing Formal Evaluations of Unconfirmed Penicillin Allergies in a Pediatric Hospital
Saturday, Nov 11	Quality Improvement	Monitor 21	12:20 pm PT	P260	An Evaluation Of Outcomes In Penicillin Allergic Stem Cell Transplant Patients
Saturday, Nov 11	Quality Improvement	Monitor 21	12:35 pm PT	P261	Assessment of Pediatrics Resident Knowledge Regarding Epinephrine Autoinjectors
Saturday, Nov 11	Rhinitis, Other Upper Airway Disorders	Monitor 18	11:35 am PT	P273	Assessing the Effects of Area Deprivation Index on Outcome Measures in Patients with Chronic Rhinosinusitis
Saturday, Nov 11	Rhinitis, Other Upper Airway Disorders	Monitor 18	11:50 am PT	P274	Joint Pain and Sinus Scores in 3 Populations of Aspirin-Exacerbated Respiratory Disease Patients
Saturday, Nov 11	Rhinitis, Other Upper Airway Disorders	Monitor 18	12:05 pm PT	P275	Actigraphy as an Objective Measure of Sleep Disruption in Chronic Rhinosinusitis
Saturday, Nov 11	Skin Disorders	Monitor 20	11:35 am PT	P289	Atopic Dermatitis Patient Experience With Discussing and Addressing Mental Health Concerns with Allergists
Saturday, Nov 11	Skin Disorders	Monitor 20	11:50 am PT	P290	Allergic Diseases and Allergen Sensitization in Patients with Alopecia Areata
Saturday, Nov 11	Skin Disorders	Monitor 20	12:05 pm PT	P291	Atopic & Inflammatory Skin Conditions Amongst People Experiencing Homelessness: Insights from Miami Street Medicine
Sunday, Nov 12	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	11:35 am PT	P018	Effect of Upper Respiratory Tract Infection on the Pharmacokinetics and Pharmacodynamics of Intranasal Epinephrine
Sunday, Nov 12	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	11:50 am PT	P019	Healthcare Disparities Investigated in an Innovative Multicenter General Pediatric Directed Pathway to Remove Penicillin Allergies
Sunday, Nov 12	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	12:05 pm PT	P020	Improving the Management of Pediatric Anaphylaxis in the Emergency Department at a Tertiary Care Hospital
Sunday, Nov 12	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	12:20 pm PT	P021	Risk Factors For Systemic Reactions In Rush Aeroallergen Immunotherapy
Sunday, Nov 12	Adverse Drug Reactions, Insect Reactions, Anaphylaxis	Monitor 11	12:35 pm PT	P022	Outcomes of Patients with Left Ventricular Assisted Device (LVAD) and Penicillin-Allergy Label
Sunday, Nov 12	Aerobiology, Allergens, Allergen Extracts	Monitor 21	11:35 am PT	P036	A Breath of Fresh Information on Air Cleaning Technology
Sunday, Nov 12	Aerobiology, Allergens, Allergen Extracts	Monitor 21	11:50 am PT	P037	Health Consequences and Remediation of Mold Exposure Following Natural Disasters: A Scoping Review
Sunday, Nov 12	Allergy Diagnostics and Immunotherapy	Monitor 15	12:20 pm PT	P045	Minimally Invasive Point of Care Total IgE Quantification is Clinically Equivalent to Laboratory Reference Standard
Sunday, Nov 12	Allergy Diagnostics and Immunotherapy	Monitor 15	12:35 pm PT	P046	Preferred Allergy Immunotherapy Treatment and Needle Phobia Among Children with Allergic Rhinitis: Survey Results
Sunday, Nov 12	Angioedema/Urticaria	Monitor 12	11:35 am PT	P067	Real-World Effectiveness of Omalizumab in Patients Treated for Chronic Spontaneous Urticaria
Sunday, Nov 12	Angioedema/Urticaria	Monitor 12	11:50 am PT	P068	Perspectives of Medical Care Among Patients With Hereditary Angioedema Within Underrepresented Racial or Ethnic Groups
Sunday, Nov 12	Angioedema/Urticaria	Monitor 12	12:05 pm PT	P069	Diagnosing Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) – A Real World ACARE Survey
Sunday, Nov 12	Angioedema/Urticaria	Monitor 12	12:20 pm PT	P070	Refining Prevalence Estimates of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH)
Sunday, Nov 12	Angioedema/Urticaria	Monitor 12	12:35 pm PT	P071	Efficacy and Safety of CT-P39 compared to Reference Omalizumab in Patients with Chronic Spontaneous Urticaria
Sunday, Nov 12	Angioedema/Urticaria	Monitor 13	11:35 am PT	P089	Relationship Between D-Dimer Levels And Clinical Activity Of Spontaneous Chronic Urticaria.
Sunday, Nov 12	Angioedema/Urticaria	Monitor 13	11:50 am PT	P090	Omalizumab Use in Patients with Chronic Spontaneous Urticaria: A Real-World Survey in the United States
Sunday, Nov 12	Angioedema/Urticaria	Monitor 13	12:05 pm PT	P091	Burden of Hereditary Angioedema: Findings from a Multinational Survey of Caregivers for Adult Patients
Sunday, Nov 12	Angioedema/Urticaria	Monitor 13	12:20 pm PT	P092	Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack Management
Sunday, Nov 12	Asthma, Other Lower Airway Disorders	Monitor 14	11:35 am PT	P117	Dupilumab Efficacy in Children With/Without Allergic Asthma in the Presence of Elevated Type 2 Biomarkers
Sunday, Nov 12	Asthma, Other Lower Airway Disorders	Monitor 14	11:50 am PT	P118	Dupilumab Reduces Corticosteroid Use in Children With Uncontrolled Moderate-to-severe Asthma Regardless of Exacerbation History
Sunday, Nov 12	Asthma, Other Lower Airway Disorders	Monitor 14	12:05 pm PT	P119	Assessment of the Immune Status in Obese Asthma Patients
Sunday, Nov 12	Asthma, Other Lower Airway Disorders	Monitor 14	12:20 pm PT	P120	Fractional Exhaled Nitric Oxide (FeNO) is a Stable Biomarker in Patients with Uncontrolled Asthma
Sunday, Nov 12	Asthma, Other Lower Airway Disorders	Monitor 14	12:35 pm PT	P121	Trusted Messenger Virtual Asthma Coaching Intervention Impacts Asthma Self-Management
Sunday, Nov 12	Asthma, Other Lower Airway Disorders	Monitor 15	11:35 am PT	P137	Randomized attention-placebo controlled trial of a digital self-management platform for adult asthma
Sunday, Nov 12	Asthma, Other Lower Airway Disorders	Monitor 15	11:50 am PT	P138	Respiratory Functions in Girls with Varying Levels of Physical Activity
Sunday, Nov 12	Asthma, Other Lower Airway Disorders	Monitor 15	12:05 pm PT	P139	Association Between Baseline Characteristics and Oral Corticosteroid Reduction in Patients With Oral Corticosteroid-Dependent Severe Asthma
Sunday, Nov 12	Clinical Immunology, Immunodeficiency	Monitor 16	11:35 am PT	P167	Clinical Assessment of Safety, Pharmacokinetics, and Efficacy of Immune Globulin Intravenous 10% in Pediatric Patients
Sunday, Nov 12	Clinical Immunology, Immunodeficiency	Monitor 16	11:50 am PT	P168	SARS-CoV2 Specific Antibody Responses to COVID-19 Vaccination in Common Variable Immunodeficiency
Sunday, Nov 12	Clinical Immunology, Immunodeficiency	Monitor 16	12:20 pm PT	P170	Long-Term Outcomes with Immune Globulin Subcutaneous 16.5% in Treatment of Primary Immunodeficiency
Sunday, Nov 12	Clinical Immunology, Immunodeficiency	Monitor 16	12:35 pm PT	P171	Nasal Powder Methyl-cellulose Alone or with European Wild Garlic as Mucosal Barrier Against Viruses
Sunday, Nov 12	Food Allergy	Monitor 17	11:35 am PT	P197	Using Instagram to Provide High-Quality Food Allergy Education and Awareness
Sunday, Nov 12	Food Allergy	Monitor 17	11:50 am PT	P198	Food Allergies Associations with Anxiety and Depression Disorders in the US General Population
Sunday, Nov 12	Food Allergy	Monitor 17	12:05 pm PT	P199	Methodology of the Cross-Sectional Study for Global Prevalence and Severity of Food Allergies (ASSESS FA)
Sunday, Nov 12	Food Allergy	Monitor 17	12:20 pm PT	P200	Food Allergies and Autism Spectrum Disorder: A Comparative Study of Sensitization in Children.
Sunday, Nov 12	Food Allergy	Monitor 17	12:35 pm PT	P201	Impact of dupilumab on food-specific IgE levels
Sunday, Nov 12	Other Medicare Reimbursement Trends in Allergy/Immunology	Monitor 19	11:35 am PT	P242	Changes in Medicare Reimbursement for Allergy and Immunology Procedures: A State-by-State Analysis 2013-2022
Sunday, Nov 12	Other Medication Adherence	Monitor 19	11:50 am PT	P243	HealthBeacon's Injection Care Management System (ICMS); Improving Adherence to Injectable Medication for Respiratory Disease
Sunday, Nov 12	Other SARS-CoV-2 infection	Monitor 19	12:05 pm PT	P244	Double blind randomized controlled trial of saline solution gargling and nasal rinsing in SARS-CoV-2 infection
Sunday, Nov 12	Other Stomach or GI	Monitor 19	12:20 pm PT	P245	A Study of Dupilumab Versus Placebo in Patients With Eosinophilic Gastritis With/Without Eosinophilic Duodenitis
Sunday, Nov 12	Quality Improvement	Monitor 20	12:20 pm PT	P256	Continued Evaluation Of Penicillin Allergy Delabeling And The Impact Of Resident Education On Current Efforts
Sunday, Nov 12	Quality Improvement	Monitor 20	12:35 pm PT	P257	Evaluation of an Allergy and Immunology Handbook to Improve Medical Education for Fellows
Sunday, Nov 12	Quality Improvement	Monitor 21	12:20 pm PT	P262	Building a Pediatric Drug Allergy Evaluation Program
Sunday, Nov 12	Quality Improvement	Monitor 21	12:35 pm PT	P263	Why Tolerate Food Intolerance
Sunday, Nov 12	Rhinitis, Other Upper Airway Disorders	Monitor 18	11:35 am PT	P276	Impacts of Tethered Education for Clinicians and Patients in Management of Severe Nasal Polyps (NPs)
Sunday, Nov 12	Rhinitis, Other Upper Airway Disorders	Monitor 18	11:50 am PT	P277	Improved sleep quality and timing in patients with Chronic-rhinosinusitis after use of deep-delivery nasal corticosteroid
Sunday, Nov 12	Skin Disorders	Monitor 20	11:35 am PT	P292	Seum IgE reduction after dupilumab therapy in patients with atopic dermatitis in southern Puerto Rico
Sunday, Nov 12	Skin Disorders	Monitor 20	11:50 am PT	P293	Common Contact Allergens Found by Patch Testing in the Allergist’s Office
Sunday, Nov 12	Skin Disorders	Monitor 20	12:05 pm PT	P294	Empowering People of Color (POC) with Moderate-to-severe Atopic Dermatitis to Advocate for Multidisciplinary Care

No FAQ Found